← All indications
Chronic Pain
Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.
Drugs by status
Approved for this indication (13)
Phase 4 trials (57)
- diclofenac
- hydrocodone
- propofol
- vitamin d3
- methylprednisolone
- amitriptyline
- oxytocin
- urea
- ketamine
- doxycycline
- ibuprofen
- betamethasone
- cannabidiol
- palmitoylethanolamide
- sibelium
- gabapentin
- sevoflurane
- ethinyl estradiol
- naltrexone
- guanfacine
- haloperidol
- esketamine
- ketorolac
- platelet-rich plasma
- naproxen
- rimabotulinumtoxinB
- ropivacaine
- acetaminophen
- lidocaine
- hyaluronic acid
- +27 more
Phase 3 trials (23)
Phase 2 trials (39)
- acetazolamide
- aeg33773
- alisporivir
- aqx-1125
- asp3652
- bee venom
- bicifadine
- ketotifen
- methylphenidate
- eplivanserin
- imc-1
- levodopa
- carbidopa
- krill oil
- loxoprofen
- mexiletine
- vitamin c
- ribavirin
- saf-312
- silodosin
- siltuximab
- testosterone
- lacosamide
- psilocybin
- riboflavin
- minocycline
- quinine
- baclofen
- ergocalciferol
- omega-3 fatty acids
- +9 more
Phase 1 trials (35)
- simvastatin
- metformin
- 18f-ftc-146
- azd-2066
- buspirone
- cinnamon
- axomadol
- fulranumab
- icosapent ethyl
- magnesium oxide
- medi7352
- pf-04457845
- pf-04531083
- azd1386
- caffeine
- sulfasalazine
- sunflower oil
- tolbutamide
- valaciclovir
- buglossoides oil
- varenicline
- hydrochlorothiazide
- faxeladol
- pramipexole
- hyaluronidase (bovine)
- omeprazole
- fludeoxyglucose f-18
- Anrikefon
- Otenaproxesul
- cntx-6970
- +5 more
Other trials (38)
- norgestrel
- ketoprofen
- arnica
- cocoa bean
- alpha-lipoic acid
- cycloserine
- etanercept
- gemcitabine
- paclitaxel
- zopiclone
- hypericum perforatum
- ozone
- lavender
- levorphanol tartrate
- bromocriptine
- epinephrine
- rocuronium
- taurine
- collagen
- allogeneic adipose derived mesenchymal stem cell
- boswellia serrata
- polyclonal avian immunoglobulin igy containing specific igy against e. coli f18ab and s. typhimurium
- menthol
- lactobacillus plantarum
- opiate with bolus
- amisulpride
- calendula officinalis
- ircodone
- misoprostol
- oxygen
- +8 more
Organizations
Organization Involved with Phase 4 Indications (78)
- Forest Laboratories
- Pfizer
- Zambon
- Endo Pharmaceuticals
- Member Companies of the Opioid PMR Consortium
- MedVadis Research Corporation
- Mundipharma
- Boehringer Ingelheim
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute of Nursing Research (NINR)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institute on Drug Abuse (NIDA)
- Region Syddanmark
- Rockefeller University
- University of Pittsburgh
- Baskent University
- Case Western Reserve University
- Cukurova University
- Harvard University
- Duke University
- University of Washington
- Mahidol University
- McGill University
- Mustafa Kemal University
- New York University
- Northwestern University
- Queen's University, Belfast
- Siriraj Hospital
- Stanford University
- +48 more
Organization Involved with Phase 3 Indications (55)
- Zars Pharma Inc.
- 9305-9954 Quebec Inc
- Cephalon
- Bausch Health Companies
- Grunenthal
- Alza
- Purdue Pharmaceuticals
- BioDelivery Sciences International
- Braeburn Pharmaceuticals
- Mallinckrodt
- Nektar Therapeutics
- Nycomed
- Pharmaceutical Research Management srl
- Solvay
- Teva
- Zogenix, Inc.
- United States Air Force
- Alexandria University
- Cairo University
- University of London
- Federal University of Health Science of Porto Alegre
- Helse Møre og Romsdal HF
- Hôpital Raymond Poincaré
- Institut National de la Santé Et de la Recherche Médicale, France
- Masaryk University
- Los Angeles Biomedical Research Institute
- McMaster University
- Norwegian University of Science and Technology
- University of Michigan
- University of South Florida
- +25 more
Organization Involved with Phase 2 Indications (56)
- Neurex
- Debiopharm
- Aegera Therapeutics
- Sanofi
- Shionogi
- Novartis
- Allergan
- Hamilton Health Sciences Corporation
- Virios Therapeutics
- Labtec GmbH
- Durect
- Syntrix Biosystems, Inc.
- National Institute of General Medical Sciences (NIGMS)
- National Institute of Neurological Disorders and Stroke (NINDS)
- National Institute on Aging (NIA)
- University of Pennsylvania
- Boston University
- Cancer Research Network
- Cornell University
- Federal University of Rio Grande do Sul
- Georgetown University
- Gillette Children's Specialty Healthcare
- Hanyang University
- Johns Hopkins University
- Mclean Hospital
- Radboud University
- Rhode Island Hospital
- The Rogosin Institute
- University of Florida
- University of Leeds
- +26 more
Organization Involved with Phase 1 Indications (28)
- Amgen
- AstraZeneca
- CDA Research Group, Inc.
- Centrexion Therapeutics
- University of Arizona
- Central South University
- National College of Natural Medicine
- Sichuan University
- University of Kansas
- Wayne State University
- Mayo Clinic
- Columbia University
- University of California, San Francisco
- Jiao Tong University
- Algorithme Pharma Inc
- Liaoning Hospital of Traditional Chinese Medicine
- Pennsylvania State University
- Bio-Kinetic Clinical Applications
- Kyushu Clinical Pharmacolgy Reasearch Clinic
- Humboldt University
- ICON
- Metagenics, Inc.
- General Electric
- 3VM Research Group, Inc.
- Liaoning Medical University
- Antibe Therapeutics
- Haisco Pharmaceutical
- University Clermont Auvergne
Organization Involved with Other Experimental Indications (30)
- IgNova GmbH
- Natural Immune Systems Inc
- Centre Hospitalier Departemental Vendee
- Centre Hospitalier Universitaire de Nīmes
- Guangzhou Medical University
- Haydarpasa Numune State Hospital
- Postgraduate Institute of Medical Education and Research
- Seoul National University
- University of Athens
- Yonsei University
- NIS Labs
- Asklepieion General Hospital
- Hebrew University
- University Hospital, Rijeka
- Smolensk State Medical Academy
- State University of New York, Syracuse
- University of Nimes
- Johannes Gutenburg University
- Massachusetts Institute of Technology
- SCOPE International AG
- Klinar CRO
- CenTrial GmbH
- Pharmasolutions4U
- Aretaieion University
- ISTITUTO REGINA ELENA
- Federal University of Sao Paulo
- Toronto Poly Clinic
- American Association of Sensory Electrodiagnostic Medicine
- Kutahya Medical Sciences University
- General Hospital Pula